Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells

Area of Science:

• Oncology
• Cancer Biology
• Translational Medicine

Background:

• Metastasis is the primary cause of cancer-related mortality.
• Circulating tumor cells (CTCs) are key drivers of distant metastasis and indicate a poor prognosis.
• Current treatments primarily focus on the primary tumor, with limited direct impact on metastasis-initiating cells.

Purpose of the Study:

• To explore novel therapeutic strategies for metastasis prevention.
• To identify molecular and cellular targets within circulating tumor cells (CTCs) and disseminated tumor cells.
• To address knowledge gaps in CTC biology for developing effective metastasis suppression therapies.

Main Methods:

• Review and analysis of current literature on CTC biology and metastasis.
• Identification of key cellular phenotypes and mechanisms of metastatic CTCs, including stem-like and hybrid epithelial-mesenchymal states.
• Evaluation of therapeutic strategies targeting CTCs, CTC clusters, and disseminated tumor cells.

Main Results:

• Metastatic CTCs possess stem-like properties, evade immune surveillance, and exhibit therapy resistance.
• Targeting CTCs and their progenitors presents a viable approach for metastasis prevention.
• Existing therapeutic strategies indirectly impact metastasis-initiating cells, highlighting a need for direct targeting.

Conclusions:

• Developing therapeutics that target the unique features of metastatic CTCs is crucial for effective metastasis suppression.
• Further research into CTC biology, including their interactions and survival mechanisms, is essential.
• A shift towards direct targeting of metastasis-initiating cells could significantly improve cancer treatment outcomes.